In this article, we examine ongoing challenges shaping target-based drug discovery and highlight how new technologies and ...

This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...

Zhongyao Ma, PhD, holds a bachelor’s degree in biology from Shanghai Jiao Tong University and a PhD in genetics and developmental biology from the University of Georgia, U.S. His research focused on ...

A significant portion of disease-relevant proteins remain “undruggable” by traditional therapeutic approaches, representing a major hurdle in drug discovery. Targeted protein degradation (TPD) is ...

This article and associated images are based on a poster originally authored by Paulina Chorobik, Maciej B. Olszewski, John Vincent and Kirsty Winn and presented at ELRIG Drug Discovery 2025 in ...

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Explore the role of patient-derived biology in enhancing antibody-drug conjugates for more effective cancer treatment.